Does TOFACITINIB Cause Congenital anomaly? 221 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Congenital anomaly have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
221
Reports of Congenital anomaly with TOFACITINIB
0.1%
of all TOFACITINIB reports
19
Deaths
5
Hospitalizations
How Dangerous Is Congenital anomaly From TOFACITINIB?
Of the 221 reports, 19 (8.6%) resulted in death, 5 (2.3%) required hospitalization, and 4 (1.8%) were considered life-threatening.
Is Congenital anomaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Congenital anomaly?
OXYCODONE (683)
ACETAMINOPHEN\OXYCODONE (460)
ACETAMINOPHEN\HYDROCODONE (439)
TRAMADOL (348)
HYDROMORPHONE (341)
LEVETIRACETAM (334)
ONDANSETRON (334)
ABATACEPT (322)
BUPRENORPHINE (296)
MORPHINE (293)
Which TOFACITINIB Alternatives Have Lower Congenital anomaly Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN